{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:10:59Z","timestamp":1722903059368},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Hypertrophic cardiomyopathy (HCM) in pediatric solid organ transplant recipients has been reported in association with use of calcineurin inhibitors. However, data on the incidence and prevalence of HCM in adult posttransplant patients are limited. We sought to describe the clinical characteristics of solid organ transplant recipients who were diagnosed with HCM from 2011 to 2021 at a single center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Patients who had undergone solid organ transplant and exhibited left ventricular hypertrophy with left ventricular wall thickness \u226513 mm on transthoracic echocardiography were included. Clinical history, pedigree analysis, clinical genetic testing, transthoracic echocardiography, cardiac magnetic resonance imaging, treatment, and follow-up testing results were collected. Categorical variables were described as n (%). Continuous variables were described with medians and interquartile ranges and compared using the Wilcoxon rank-sum and Kruskal-Wallis tests. A 2-sided <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 was considered statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Three lung, 5 kidney, and 4 liver transplant recipients from 12 different families were included. Seven patients (58%) did not carry a preexisting diagnosis of hypertension, and none had a history of aortic or subaortic stenosis. A majority of patients exhibited asymmetric septal hypertrophy (67%; medial septal thickness versus left ventricular posterior wall thickness 17 versus 13 mm; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and dynamic left ventricular outflow tract (LVOT) obstruction (58%). All patients were managed long term with calcineurin inhibitors. Clinical genetic testing in 6 patients identified 2 with disease-causing variants in 2 sarcomere genes, myosin binding protein-C and myosin heavy chain 7. Four patients (33%) underwent successful septal reduction therapy for treatment of symptomatic LVOT obstruction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Symptomatic HCM with dynamic LVOT obstruction can develop in solid organ transplant recipients, and genetic testing can identify individuals with sarcomeric HCM. Medical management and septal reduction therapies are treatment options for severe symptomatic disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001279","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T02:00:45Z","timestamp":1639447245000},"page":"e1279","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"8","author":[{"given":"Nosheen","family":"Reza","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"De Feria","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Chowns","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Hoffman-Andrews","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Hornsby","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Marzolf","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Atluri","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard C.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali Tiku","family":"Owens","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia.","volume":"14","author":"Rigatto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/tri.13773","article-title":"Prospective assessment of subclinical cardiovascular damage and associated factors in liver transplant recipients.","volume":"34","author":"Memaran","year":"2021","journal-title":"Transpl Int"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/tri.12862","article-title":"Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation.","volume":"29","author":"Cruzado","year":"2016","journal-title":"Transpl Int"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.transproceed.2021.01.026","article-title":"Changes in cardiac structure and function before and after renal transplantation: a longitudinal study.","volume":"53","author":"Jhinger","year":"2021","journal-title":"Transplant Proc"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007890-200008270-00006","article-title":"Long-term changes in left ventricular hypertrophy after renal transplantation.","volume":"70","author":"Rigatto","year":"2000","journal-title":"Transplantation"},{"key":"R6-20240805","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11897-019-00435-0","article-title":"From hypertrophy to heart failure: what is new in genetic cardiomyopathies.","volume":"16","author":"Reza","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy.","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/S0140-6736(21)01205-8","article-title":"Hypertrophic cardiomyopathy: a practical approach to guideline directed management.","volume":"398","author":"Ommen","year":"2021","journal-title":"Lancet"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(95)90011-X","article-title":"Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.","volume":"345","author":"Atkison","year":"1995","journal-title":"Lancet"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-3046.2005.00260.x","article-title":"Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.","volume":"9","author":"Jarzembowski","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1399-3046.2006.00633.x","article-title":"Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.","volume":"11","author":"Turska-Kmie\u0107","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R13-20240805","first-page":"116","article-title":"Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.","volume":"13","author":"Dehghani","year":"2010","journal-title":"Arch Iran Med"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3046.2001.00052.x","article-title":"Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.","volume":"5","author":"Chang","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0002-9149(98)00126-X","article-title":"Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation.","volume":"81","author":"Chang","year":"1998","journal-title":"Am J Cardiol"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(95)90153-1","article-title":"Immunosuppressive drugs and hypertrophic cardiomyopathy.","volume":"345","author":"Dhawan","year":"1995","journal-title":"Lancet"},{"key":"R17-20240805","first-page":"6633085","article-title":"Systemic lupus erythematosus complicated with hypertrophic cardiomyopathy: a case report and literature review.","volume":"2021","author":"Ma","year":"2021","journal-title":"Case Rep Cardiol"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0041-1345(02)03917-9","article-title":"Hypertrophic cardiomyopathy in a renal transplant recipient: a case report.","volume":"35","author":"Akioka","year":"2003","journal-title":"Transplant Proc"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/rheumatology\/kex310","article-title":"Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis.","volume":"56","author":"Noda","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20240805","first-page":"1352","article-title":"Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.","volume":"125","author":"Liu","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1345\/aph.10299","article-title":"Lack of tacrolimus-induced cardiomyopathy.","volume":"35","author":"Coley","year":"2001","journal-title":"Ann Pharmacother"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00007890-200209270-00015","article-title":"Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine a after liver transplant.","volume":"74","author":"Roberts","year":"2002","journal-title":"Transplantation"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.CIR.101.20.2431","article-title":"Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.","volume":"101","author":"Lim","year":"2000","journal-title":"Circulation"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.120.052384","article-title":"Cooperative binding of ETS2 and NFAT links Erk1\/2 and calcineurin signaling in the pathogenesis of cardiac hypertrophy.","volume":"144","author":"Luo","year":"2021","journal-title":"Circulation"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy.","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.","volume":"45","author":"Adabag","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2047487319828474","article-title":"Risk factors for atrial fibrillation in hypertrophic cardiomyopathy.","volume":"28","author":"Philipson","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00003088-200241050-00005","article-title":"Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.","volume":"41","author":"Jones","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe Registry.","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:03:38Z","timestamp":1722834218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001279","relation":{},"ISSN":["2373-8731"],"issn-type":[{"type":"electronic","value":"2373-8731"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}